Fidelity Investments’s Minerva Neurosciences NERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-25
| Closed | -$41 | – | 5439 |
|
|
2025
Q1 | $43 | Buy |
+25
| New | +$49 | ﹤0.01% | 5178 |
|
|
2024
Q1 | – | Sell |
-491,746
| Closed | -$3.02M | – | 5595 |
|
|
2023
Q4 | $3.02M | Hold |
491,746
| – | – | ﹤0.01% | 2208 |
|
|
2023
Q3 | $3.39M | Hold |
491,746
| – | – | ﹤0.01% | 2145 |
|
|
2023
Q2 | $4.49M | Buy |
+491,746
| New | +$2.6M | ﹤0.01% | 2095 |
|
|
2022
Q4 | – | Sell |
-28,272
| Closed | -$261K | – | 5503 |
|
|
2022
Q3 | $261K | Sell |
28,272
-21,855
| -44% | -$129K | ﹤0.01% | 2976 |
|
|
2022
Q2 | $166K | Sell |
50,127
-1
| -0% | -$4 | ﹤0.01% | 3171 |
|
|
2022
Q1 | $333K | Buy |
50,128
+21,843
| +77% | +$134K | ﹤0.01% | 3106 |
|
|
2021
Q4 | $181K | Sell |
28,285
-21,025
| -43% | -$198K | ﹤0.01% | 2976 |
|
|
2021
Q3 | $686K | Hold |
49,310
| – | – | ﹤0.01% | 2747 |
|
|
2021
Q2 | $915K | Hold |
49,310
| – | – | ﹤0.01% | 2679 |
|
|
2021
Q1 | $1.15M | Sell |
49,310
-125
| -0.3% | -$3.12K | ﹤0.01% | 2558 |
|
|
2020
Q4 | $925K | Sell |
49,435
-7,686
| -13% | -$194K | ﹤0.01% | 2542 |
|
|
2020
Q3 | $1.45M | Sell |
57,121
-128,756
| -69% | -$3.48M | ﹤0.01% | 2362 |
|
|
2020
Q2 | $5.37M | Sell |
185,877
-57,487
| -24% | -$3.37M | ﹤0.01% | 2028 |
|
|
2020
Q1 | $11.7M | Sell |
243,364
-10,000
| -4% | -$603K | ﹤0.01% | 1644 |
|
|
2019
Q4 | $14.4M | Sell |
253,364
-23,963
| -9% | -$1.06M | ﹤0.01% | 1721 |
|
|
2019
Q3 | $17.2M | Hold |
277,327
| – | – | ﹤0.01% | 1629 |
|
|
2019
Q2 | $12.5M | Sell |
277,327
-69,687
| -20% | -$3.49M | ﹤0.01% | 1808 |
|
|
2019
Q1 | $21.8M | Sell |
347,014
-4,138
| -1% | -$249K | ﹤0.01% | 1570 |
|
|
2018
Q4 | $18.9M | Hold |
351,152
| – | – | ﹤0.01% | 1569 |
|
|
2018
Q3 | $35.3M | Sell |
351,152
-219,897
| -39% | -$16.5M | ﹤0.01% | 1443 |
|
|
2018
Q2 | $37.7M | Hold |
571,049
| – | – | ﹤0.01% | 1417 |
|
|
2018
Q1 | $28.6M | Sell |
571,049
-13,919
| -2% | -$669K | ﹤0.01% | 1558 |
|
|
2017
Q4 | $28.3M | Sell |
584,968
-122,631
| -17% | -$6.08M | ﹤0.01% | 1556 |
|
|
2017
Q3 | $43M | Hold |
707,599
| – | – | 0.01% | 1372 |
|
|
2017
Q2 | $50.1M | Buy |
707,599
+85,000
| +14% | +$5.5M | 0.01% | 1288 |
|
|
2017
Q1 | $40.3M | Hold |
622,599
| – | – | 0.01% | 1421 |
|
|
2016
Q4 | $58.5M | Hold |
622,599
| – | – | 0.01% | 1224 |
|
|
2016
Q3 | $70.3M | Hold |
622,599
| – | – | 0.01% | 1153 |
|
|
2016
Q2 | $50.9M | Buy |
622,599
+276,859
| +80% | +$17.6M | 0.01% | 1267 |
|
|
2016
Q1 | $17M | Hold |
345,740
| – | – | ﹤0.01% | 1744 |
|
|
2015
Q4 | $16.8M | Hold |
345,740
| – | – | ﹤0.01% | 1762 |
|
|
2015
Q3 | $14.5M | Hold |
345,740
| – | – | ﹤0.01% | 1788 |
|
|
2015
Q2 | $16M | Hold |
345,740
| – | – | ﹤0.01% | 1827 |
|
|
2015
Q1 | $13.8M | Buy |
345,740
+158,240
| +84% | +$6.55M | ﹤0.01% | 1882 |
|
|
2014
Q4 | $9.06M | Hold |
187,500
| – | – | ﹤0.01% | 2035 |
|
|
2014
Q3 | $9.07M | Buy |
+187,500
| New | +$9.97M | ﹤0.01% | 2050 |
|
Other funds holding NERV
AC
ACM
Fidelity Investments's NERV Position: Q2 2025 in Review
Fidelity Investments sold out of Minerva Neurosciences (NERV) in Q2 2025, closing a stake of 25 shares — an estimated $41 sold.
Fidelity Investments first reported a position in NERV in Q3 2014 and held it in 37 quarters. The position peaked at $70.3M in Q3 2016. 21 funds tracked by Wall St. Rank hold NERV as of Q2 2025.
- Fidelity Investments reported no remaining Minerva Neurosciences position as of Q2 2025 after selling out during the quarter.
- Fidelity Investments sold 25 Minerva Neurosciences shares in Q2 2025, an estimated $41.
- Fidelity Investments first reported a position in Minerva Neurosciences in Q3 2014 and held it in 37 quarters.
- Fidelity Investments's Minerva Neurosciences position peaked at $70.3M in Q3 2016.
- 21 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q2 2025.
Based on Fidelity Investments's 13F filing for Q2 2025, filed 14 Aug 2025.